Pancreatic Cancer Research

ResearcherSichuan UniversityActive in the last 2 years

Kexun Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8664-3581; OpenAlex author ID A5101189429. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 5

  1. Pancreatic Cancer: Pathogenesis and Clinical Studies. Co-author DOI 10.1002/mco2.70162↗
  2. Signalling in pancreatic cancer: from pathways to therapy. Co-author DOI 10.1080/1061186x.2023.2274806↗
  3. Integratively Genomic Analysis Reveals the Prognostic and Immunological Characteristics of Pyroptosis and Ferroptosis in Pancreatic Cancer for Precision Immuno… Co-author DOI 10.3389/fcell.2022.826879↗
  4. S-1 or gemcitabine adjuvant therapy in resected pancreatic cancer: a cost-effectiveness analysis based on the JASPAC-01 trial. Co-author DOI 10.1080/14737167.2020.1677155↗
  5. Cost-effectiveness analysis of adjuvant treatment for resected pancreatic cancer in China based on the ESPAC-4 trial. Co-author DOI 10.2147/cmar.s172704↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qiu Li · 3 shared papers, 2018–2023 · strength 0.38
  2. Hong Zhu · 1 shared paper, 2025 · strength 0.37
  3. Jiaxing Huang · 2 shared papers, 2018–2020 · strength 0.18
  4. Weiting Liao · 2 shared papers, 2018–2020 · strength 0.18
  5. Shi H · 1 shared paper, 2022 · strength 0.17
  6. Ting Yu · 1 shared paper, 2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.